Synergy Health

Author Archives

  • New TVAM Study Published in Journal of Endovascular Therapy

    A new study on Transvascular Autonomic Modulation (TVAM) was published in the June 2014 edition of the Journal of Endovascular Therapy. The study compares the efficacy of the TVAM procedure vs. traditional balloon angioplasty in improving cardiovascular autonomic nervous system (ANS) dysfunction in Multiple Sclerosis (MS) patients. Readthe full study here: http://jevt.org/doi/full/10.1583/13-4605MR.1 Transvascular Autonomic Modulation: […]

  • QSART Assessment of Venous Autonomic Modulation

    QSART Assessment of Venous Autonomic Modulation Authors: Arata M., Debarge P. Institution: Synergy Health Concepts, Newport Beach, CA, USA Background Diagnostic tests used to assess autonomic nervous system (ANS) function such as heart rate variability (HRV) have been applied in MS and track with physical disability and disease progression. Sympathetic activity in particular correlates with […]

  • Study Investigates Safety and Efficacy of TVAM Procedure

    A new study on TVAM (transvascular autonomic modulation) was published in the April 2014 edition of ACTA PHLEBOLOGICA (Edizioni Minerva Medica), a Journal on Phlebology. The study investigates the safety and efficacy of the TVAM procedure. Download the full study here: http://www.minervamedica.it/en/journals/acta-phlebologica/article.php?cod=R43Y2014N01A0019 Transvascular Autonomic Modulation, Initial Assessment of Safety Authors: Arata M., Debarge P. Institution: […]

  • Transvascular Autonomic Modulation: Novel Venous Therapy For Autonomic Dysfunction

    Authors: M. Arata, Z. Sternberg Institution: Synergy Health Concepts, Newport Beach, CA Background Chronic cerebrospinal venous insufficiency (CCSVI) has been described as a condition resulting from impaired CNS venous drainage. Venous balloon angioplasty (BA) has been performed as a treatment for CCSVI. Autonomic nervous system (ANS) dysfunction has been proposed as mechanism underlying the occurrence […]

  • Venous Transvascular Autonomic Modulation (TVAM), Initial Assessment and Safety

    Authors: Michael A. Arata, M.D. Institution: Synergy Health Concepts, Newport Beach, CA Background Patients undergoing central venous angioplasty (CVA) have demonstrated improvement in autonomic parameters. We hypothesize that this results from stimulation of low pressure baroreceptors during balloon inflation. This report describes the assessment of the autonomic effect of CVA using HRV parameters. Further, the […]

  • Alterations in Hypothalamic Pituitary Adrenal Axis Following Central Venous Balloon Dilation

    Authors: Michael A. Arata, M.D., Zohara Sternberg, Ph.D., Steven Cen, Ph.D. Institution: Synergy Health Concepts, Newport Beach, CA Purpose Chronic cerebrospinal venous insufficiency (CCSVI) has been described as a condition resulting from impaired CNS venous drainage in multiple sclerosis (MS) patients. Venous balloon angioplasty (BA) has been performed as a treatment for CCSVI, although a […]

  • Autonomic Dysfunction Testing in Patients Seeking CCSVI Treatment

    Authors: M Arata1, P DeGuzman2, F DeBarge-Igoe3 Institutions: 1Synergy Health Concepts, Newport Beach, CA, 2Synergy Health, Newport Beach, CA Enter Objectives / Purpose Statement: Patients seeking treatment for CCSVI at our clinic commonly present with symptoms of autonomic dysfunction: fatigue, interrupted sleep, cognitive impairment, bowel and/or bladder dysfunction, thermal intolerance. Recent analysis by Zohara Sternberg […]

  • Progressive Improvement in Quality of Life After Jugular Balloon Dilation in Patients with Autonomic Dysfunction

    Authors: M Arata1, F DeBarge-Igoe2, P Grewal3, S Cen4 Institutions: 1Synergy Health Concepts, Newport Beach, CA, 2Synergy Health, Newport Beach, CA, 3Pacific Interventionalists, Newport Beach, CA, 4Division of Biokinesiology and Physical Therapy University of Southern California, Los Angeles, CA Enter Objectives / Purpose Statement: Autonomic dysfunction has been identified as a co-morbid syndrome in patients […]

  • Society of Interventional Radiology Responds to FDA Safety

    Society of Interventional Radiology Responds to FDA Safety Communication on Chronic Cerebrospinal Venous Insufficiency Treatment in Multiple Sclerosis Patients On May 10, the Food and Drug Administration issued a medical alert noting that individuals with multiple sclerosis should be aware of the risks of serious injuries and death associated with treatments for chronic cerebrospinal venous […]

  • FDA NEWS RELEASE

    For Immediate Release: May 10, 2020 Media Inquiries: Michelle Bolek, 301-796-2973, [email protected] Consumer Inquiries: 888-INFO-FDA FDA issues alert on potential dangers of unproven treatment for multiple sclerosis The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation […]

Proud Members of: